Αρχειοθήκη ιστολογίου

Δευτέρα 3 Ιουλίου 2017

Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening

Stratifying HPV-positive women for CIN3+ risk after one and two rounds of HPV-based screening:

Abstract

A main challenge of human papilloma (HPV)-based screening for cervical cancer is to adequately identify HPV-positive women at highest risk of cervical intraepithelial neoplasia grade 3 or worse, CIN3+. The prognostic value of currently used adjunct markers (HPV16/18 genotyping and reflex cytology) may change after multiple rounds of HPV-based screening because of a change in the proportion of HPV-positive women with incident infections. To this end, we re-analyzed results from the POBASCAM trial (Population Based Screening Study Amsterdam). Women were randomized to HPV/cytology co-testing (intervention group) or to cytology-only (HPV blinded; control group) at enrolment. Our analytical population consisted of women with an HPV-positive result at the second round, five years after enrolment (n=381 intervention, n=392 control). Nine-year CIN3+ risks were estimated by Kaplan Meier. HPV-positive women were stratified by risk markers: HPV16/18 genotyping, reflex cytology and preceding HPV results. When comparing one to two rounds of HPV-based screening, the prognostic value of an abnormal cytology result did not change (40.0% vs 42.3%, P=0.5617), but diminished for an HPV16/18 positive result (25.4% vs 38.0%, P=0.0132). HPV16/18 genotyping was non-discriminative in women with incident HPV infections (HPV16/18 positive 10.0% vs negative 12.1%, P=0.3193). Women from the intervention group were more likely to have incident infections compared to women from the control group (incident screen-positive results 75.6% vs 64.6%, P=0.001) Our results indicate that at a second round of HPV-based screening, risk differentiation by cytology remained strong, but was diminished for HPV 16/18 genotyping because of a larger proportion of incident infections. This article is protected by copyright. All rights reserved.


from ! Medicine by Alexandros G. Sfakianakis via Αλέξανδρος Σφακιανάκης on Inoreader http://ift.tt/2tGEQh5
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader